❤️Conditions & CareNew Clinical Guidance Issued for First Immunotherapy Targeting Pediatric Type 1 Diabetes
Experts have published practical recommendations for using the immunotherapy drug teplizumab in children and adolescents newly diagnosed with stage 3 type 1 diabetes.